Teijin EBIT per Share
The EBIT per Share of Teijin (3401.T) as of Aug 9, 2026 is -415.64 JPY. In the previous year, EBIT per Share was -89.90 JPY — a change of 362.34% (lower).
Get this data via API
Financial Data API
EBIT per Share
-415.64JPY
YoY
362.34%
Last updated:
EBIT per Share of Teijin is 2026 -415.64 JPY. EBIT per Share of Teijin was 2025 -89.90 JPY. It decreases by 362.34% lower compared to the previous year.
Access this data via the Eulerpool API
Teijin Stock analysis
What does Teijin do? Teijin Ltd is a Japanese chemical and technology conglomerate headquartered in Osaka. The company was founded in 1918 as a subsidiary of Toyobo Company to engage in cotton trading. Over the years, the company has evolved through numerous mergers and acquisitions into a diversified conglomerate with focuses in the fields of chemistry, healthcare, automotive and aerospace industries, as well as high-performance plastics.
Teijin's business model is based on the development and marketing of innovative products and technologies that meet the demands of the present time. The conglomerate sees itself as a pioneer in the production of high-tech materials and aims to contribute to a sustainable future through its research and development.
Teijin is divided into various divisions, each focused on specific target markets. The "Teijin Aramid" division produces high-performance fiber products such as Kevlar and Twaron, primarily serving the aerospace and defense industries. The subsidiary "Teijin Frontier" develops and produces high-quality fabrics for the clothing, home textiles, and automotive sectors. The "Teijin Carbon" division specializes in the production of carbon fiber reinforced plastics, supplying primarily the automotive, aerospace, and sports industries. The unit "Teijin Pharma Limited" focuses on drug development for rare diseases.
Teijin not only produces innovative materials but is also engaged in research and development. The goal is to continually improve the products and meet the ever-growing demands. In the field of artificial intelligence and robotics, the company also collaborates with other companies to accelerate development.
Teijin's products can be found in many areas. For example, the fibers of Teijin Aramid are used in ballistic protective clothing for police and military or in the production of tires for high-performance vehicles. The carbon fibers of Teijin Carbon are used to manufacture lightweight and sturdy components in the automotive, aerospace, and space industries. In the field of home textiles, fabrics from Teijin Frontier are used for sofas and decorations. Teijin Pharma Limited specializes in the development of drugs for rare diseases.
Teijin places special emphasis on sustainability and environmental protection. A system for waste reduction and reuse is utilized, and efforts for environmental protection are integrated into all areas of the company.
Overall, Teijin has a long tradition in the production of innovative products. The company has always faced the new challenges of the time and strives to provide customers with products and solutions that meet their needs and requirements. With its focus on research and development and its emphasis on sustainability, Teijin aims for a leading position in various markets. Teijin is one of the most popular companies on Eulerpool.
Frequently Asked Questions about Teijin stock
EBIT per Share of Teijin is -415.64 JPY in 2026.
EBIT per Share of Teijin changed from -89.90 JPY to -415.64 JPY, representing a 362.34% change. The value is lower than the previous year.
On Eulerpool you can find the complete historical development of EBIT per Share Teijin since 2006 – with annual values, charts, and detailed analysis.
EBIT per Share measures operating profit allocated to each outstanding share.
Access this data via the Eulerpool API
Income Statement — Teijin
All Key Metrics — Teijin
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth